1OH JM, KYUN J, CHO SW. Long-term lamivudine therapy for chronic hepatitis B in patients with and without cirrhosis [J]. Pharmacotherapy,2002,22(10) : 1226-1234.
2NEVENS F, MAIN J, HOONKOOP P, et al. Lamivudine therapy for chronic hepatitis B: A six-month randomized close-ranging study[ J ]. Gastroenterology, 1997,113(4) : 1258-1263.
3Lai C L，Hepatology，1997年，25卷，241页
4中华内科杂志，1995年，34卷，788页
5王泰龄，中华肝脏病杂志，1998年，6卷，195页
6Lai CL, Chien RN, Leung NW, et al. A one-year trial of Iamivudine for chronic hepatitis B. N Engl J Med, 1998,339: 61-68.
7Barbaro G, Zechini F, Pellicel AM, et al. Long term efficacy of interferon alpha-2a and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter-randomized trial. J Hepatol, 2001,35: 40-411.
8Polhemus ME, Aronson NE. Persistent nephrolithiasis after discontinuation of indinavir therapy. Clinical Infectious Diseases, 1998, 27: 1536.
9Lerner LB, Cendron M, Rous SN. Nephrolithiasis from indinavir, a new human immunodeficiency virus drug. Journal of Urology, 1998, 159: 2074.
10Grunke M, Valerius T, Manger B, et al. Renal dysfunction in a human immunodeficiency virus- infected patient who was treated with indinavir. Clinical Infectious Diseases, 1997, 25:1270.
